Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Galectin Therapeutics (NASDAQ:GALT) through any online brokerage.
There are no as such competitors for Galectin Therapeutics.
Galectin Therapeutics has a consensus price target of $8.50.
The stock price for Galectin Therapeutics (NASDAQ: GALT) is $2.33 last updated April 24, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Galectin Therapeutics.
Galectin Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Galectin Therapeutics.
Galectin Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.